openPR Logo
Press release

Global Liquid Biopsy Market Opportunity & Technology Outlook 2020

06-29-2017 06:03 AM CET | Health & Medicine

Press release from: Kuick Resarch

Global Liquid Biopsy Market Opportunity & Technology Outlook

Biopsy is conducted to diagnose a disease, or to assess its progression so as to take an effective clinical action either by removing the affected site surgically or by drawing samples from the target tissue to conduct investigative studies about the disease. This technique is widespread and has been used since 12th century. The techniques involving solid biopsy have without any doubt, improved with advancement in scanning processes and surgical advancement. However, the traditional biopsy methods are of no match when it comes to the effective diagnosis and prognosis of cancer, besides ailments like renal failure, infections, fertility and transplantation related issues.

Liquid biopsy, on the other hand has offered us new insights in the diagnosis of diseases. It is the blood sample tests in which biomarkers associated with different disease are evaluated to determine the progression of a disease. This has allowed the emergence of targeted personalized diagnosis with increased efficiency outcomes and decreased diagnostic errors.

Download Report:

https://www.kuickresearch.com/report-Global-Liquid-Biopsy-Market-Opportunity-&-Technology-Outlook-2020.php

The emergence of liquid biopsy plays a vital role in prognosis as well as diagnostic studies for cancer treatment. Cancer has been one of the most difficult to be diagnosed at an early stage due to its fast mutation capabilities, immunosurveillance evading properties, circumventing growth suppressors among others. Besides, the genomic structure of cancer is highly unstable and in response to the therapy administered, cancer undergoes changes in their antigenic properties induced by mutations to escape immune action. Repeated tissue biopsy to assess the regression of the disease becomes cumbersome and dangerous for the patient. Therefore, the need arises for targeted therapy emerges, allowing real time monitoring to ensure that the targeted therapy is received by the cancer cells or to adopt a different biomarker in case the cancer cells mutate.

Liquid biopsy unlike normal biopsy is a non-invasive process in which samples can be drawn from blood, serum, saliva, urine or cerebral spinal fluid. Tissue biopsy on the other hand is invasive, costly, and painful and could be even risky in number of cases. Therefore, it becomes quite exciting to investigate the opportunities presented by liquid biopsies. For cancer diagnostic studies under liquid biopsy three techniques are normally used namely circulating tumor cells (CTCs), cell-free tumor nucleic acids (ctNA) and exosomes which includes small molecules like signal proteins, microRNAs, mRNAs, lipids, and exoDNA. Diagnosis of liquid biopsy is supplemented by the advancement in next generation sequencing techniques in which tumor cells, after they are captured, have their genomic and proteomic sequences run and analyzed using computational technologies to offer insight into the biomarkers associated with the respective tumor cells, which could then be in turn used for personalized diagnostic care.

“Global Liquid Biopsy Market Opportunity & Technology Outlook 2020” Report Highlights:

* Introduction & Mechanism of Action of Liquid Biopsy
* Diagnostic Technological Advancement Supplementing Liquid Biopsy Market
* Clinical Investigation Using Cell-Free Circulating Tumor DNA for Different Indications
* Combinational Analysis on the Working of Circulating Tumor Cells & Cell-Free Tumor DNA
* Market Share of Different Liquid Biopsy Techniques
* Business Model of Liquid Biopsy Market

For Report Sample Contact: neeraj@kuickresearch.com or

visit: https://www.kuickresearch.com

Recent Publications:

* Global Cancer Immunotherapy Market & Clinical Trials Outlook 2022
* Global CAR T Cell Therapy Market & Clinical Trials Insight 2022
* Global Dendritic Cell Cancer Vaccine Market & Clinical Trials Outlook 2023
* Global Microcapsules Drug Delivery Market Opportunity Outlook 2022
* Global Controlled Drug Delivery Market & Clinical Trial Outlook 2022
* Global Cancer Antibody Drug Conjugates Market & Pipeline Insight 2022
* Global B Cell Lymphoma Market & Clinical Pipeline Insight 2022

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
Avanta Business Center 4th Floor,
Statesman House Barakhamba Road,
Connaught Place New Delhi – 110 001, India
+91-11-47067990

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Liquid Biopsy Market Opportunity & Technology Outlook 2020 here

News-ID: 600815 • Views: 405

More Releases from Kuick Resarch

Lumakras Drug Clinical Insight and Sales Forecast 2026
"Lumakras Drug Clinical Insight and Sales Forecast 2026" Report Highlights: * NSCLC Targeting Lumakras Market Opportunity (US$ Million) * Colorectal Cancer Targeting Lumakras Market Opportunity (US$ Million) * Pharmacokinetics of Lumakras (Sotorasib) * Dosage, Patent and Price Analysis * Lumakras Ongoing Clinical Trials * Global KRAS Protein Inhibitors Clinical Trials Download Report: https://www.kuickresearch.com/report-lumakras-sotorasib-sales-forecast-fda-approved-kras-inhibitor-clinical-trials-non-small-cell-lung-cancer-nslc-g12c-mutation-c30h30f2n6o3-ras-gtpase The rising burden of cancer and the increasing cancer mortality rates possesses an unmet need for the development of novel therapies in the management
Global EZH2 Inhibitor Market Opportunity, Sales and Clinical Trials Insight 2026
"Global EZH2 Inhibitor Market Opportunity, Sales and Clinical Trials Insight 2026" Report Highlights: * Global EZH2 Inhibitor Market Opportunity > US$ 1.2 Billion by 2026 * Tazverik (Tazemetostat) First Approved EZH2 Inhibitor Drug * Dosage, Price and Sales Analysis of Tazverik * Tazverik Sales Opportunity > US$ 900 Million by 2026 * Tazverik Sales Forecast 2021 Till 2026 * EZH2 Inhibitor Clinical Pipeline Overview By Company, Indication and Phase * EZH2 Inhibitor in Clinical Trials: 7 Drugs Download
Global Bispecific Antibody Market Opportunity, Drug Sales, Price and Clinical Tr …
"Global Bispecific Antibody Market Opportunity, Drug Sales, Price and Clinical Trials Insight 2028" Report Highlights: * Global Bispecific Antibody Market Opportunity: > US$ 20 Billion * Global Bispecific Antibody Market Growth Rate: 100% CAGR (2016 -2021) * Approved Bispecific Antibodies In Market: 4 Antibodies * Detailed Market Sales and Trends Insight Till 2028 * Quarterly and Yearly Sales Insight Of Approved Antibodies Till Q1 2022 * Global and Regional Market Analysis * Approved Drug Sales
Global Fibroblast Growth Factor Receptor Inhibitor Drug Market Opportunity and C …
"Global Fibroblast Growth Factor Receptor Inhibitor Drug Market Opportunity and Clinical Trials Insight 2026" Report Highlights: * Global FGFR Inhibitors Market Opportunity: > USD 4 Billion by 2026 * Role of FGFR Inhibitors in Cancer Therapy * Global FGFR Market Assessment (US$) by Region and Cancer Type Clinical and Sales Insight on Approved FGFR Inhibitors: 3 (Belvesra, Pemazyre and Truseltiq) * Dosage and Drug Price Insight on Approved FGFR Inhibitors * Comprehensive Clinical Trials Insight

All 5 Releases


More Releases for Liquid

Dual Chamber Prefilled Syringes Market 2021 by Product (Liquid/Powder, Liquid/Li …
The Dual Chamber Prefilled Syringes Market report examines the market size by vital countries/regions, product type, application, historical data, and estimate to forecast. It helps to understand the structure of the Dual Chamber Prefilled Syringes Market by recognizing its different sub-segments. Furthermore, the report focuses on key market players to determine, describe and analyze the value, market share, market competition landscape, SWOT analysis, and development plans in the next few
Liquid Biopsy Market
Liquid biopsies are non-invasive blood tests that detect tumor DNA & RNA fragments and circulating tumor cells (CTCs), which are released into the blood from the primary tumors and metastatic sites. It is a minimally invasive technology for the detection of molecular biomarkers, excluding expensive or invasive procedures. The global liquid biopsy market accounted for $634 million in 2016, and is estimated to reach
Process Liquid Analyzer Market Bolstered by at-line Process Liquid Analyzer Sale …
Process liquid analyzer acts as a watchdog for the parameters of liquid streams and industrial process and its output, thereby assisting end-users enhance plant and process productivity, process performance and profitability. On the account of process liquid analyzer lessening maintenance cost, intercepting unscheduled downtime and shielding pivotal process equipment from damages, the market has gained momentum. Besides, process liquid analyzer can be used on-line, off-line, in-line or at-line from the
Liquid Milk Market
https://www.qandqmarketresearch.com/reports/7239773/liquid-milk-market-98 In 2017, the global Liquid Milk market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Liquid Milk market based on company, product type, application and key regions. This report studies the global market size of Liquid Milk in key regions like North America, Europe, Asia
Liquid Feed Market In-depth Analysis by Top Players - Quality Liquid Feeds, ADM, …
Liquid Feed Market size may surpass USD 90 billion by 2024; according to a new research report by Global Market Insights, Inc. The rising proportion of meat consumption across the globe, in all likeliness, will be one of the essential factors shaping Liquid Feed Market trends over the forthcoming years. This is evident from the fact that pork is the most widely favored livestock meat in the world, consecutively followed by
Liquid Ammonium and Liquid Potassium Thiosulfate Market Report 2018: Segmentatio …
Global Liquid Ammonium and Liquid Potassium Thiosulfate market research report provides company profile for Koch Fertilizer, Mears Fertilizer, Kugler, Agrium, R.W. Griffin, Plant Food, Hydrite Chemical, Tessenderlo Group, Martin Midstream Partners, Poole Chem, Rentech Nitrogen and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth